<DOC>
	<DOCNO>NCT01465477</DOCNO>
	<brief_summary>Fibromyalgia clinical syndrome characterize presence chronic widespread pain accompany tenderness fatigue . Central sensitization consider major pathogenetic feature fibromyalgia . While etiology fibromyalgia incompletely understood , generally consider result interaction appropriate genetic background exposure susceptible individual various incite `` trigger '' . These include among others physical trauma , infection , stress etc . The possible role vaccination cause exacerbate fibromyalgia previously raise . Thus , gulf war syndrome , entity considerable clinical overlap fibromyalgia , consider possible link exposure multiple vaccination . More recently theory advance regard possibility vaccination - related adjuvant may induce multisystem disorder characterize symptom fatigue , cognitive impairment arthralgia ( call ASIA syndrome ) . The investigator previously establish safety efficacy influenza vaccination Rheumatoid arthritis patient . In view background considerable clinical importance ascertain efficacy safety vaccination patient suffer fibromyalgia .</brief_summary>
	<brief_title>Influenza Vaccination Fibromyalgia Patients</brief_title>
	<detailed_description>Fifty patient fibromyalgia 30 healthy , age - match control participate study . The classification fibromyalgia perform apply 1990 ACR criterion . After sign informed consent , subject vaccinate inactivated split virion vaccine , recommend WHO fall . Patients evaluate week 0 6 week later . Clinical evaluation base Fibromyalgia Impact Questionnaire 2010 Fibromyalgia Severity Scale . ESR CRP Blood collect day vaccination 6 week later . The immunogenicity vaccine test Haemagglutination inhibition ( HI ) test . Influenza virus two important surface glycoprotein : haemagglutinin ( HA ) neuraminidase ( NA ) . Antigenic classification subtyping influenza virus base two glycoprotein . HA play key role virus cell entry bind cell surface receptor , find also red blood cell certain specie . Binding red cell result haemagglutination , observe carpet agglutinate red cell bottom tube microtitre well . In HI test , antibody direct viral haemagglutinins block virus binding blood cell thus inhibits haemagglutination reaction . The pre- post immunization HI antibody test Central Virology Laboratory Israeli Ministry Health use HI test accord standard WHO procedure 16 . Sera separate , code label , store -20°C test . Sera treat receptor destroy enzyme cholera filtrate remove non-specific inhibitor , Turkey red blood cell remove non-specific agglutinin . The treated serum test HI test three antigen include vaccine : A/California ( CAL ) , A/Wisconsin B/Malaysia . The work dilution ( test dose ) antigen contain four haemagglutinin unit 25 µl antigen . Test dose dilute phosphate buffer saline ( PBS ) add serial dilution antiserum . The haemagglutinin inhibition titer determine high dilution serum completely inhibits haemagglutination red blood cell . The titer antiserum show inhibition record &lt; 10 . Humoral response define either fourfold rise titer , rise non-protective baseline level &lt; 1/40 1/40 HI antibody four week vaccination 17,18 . Geometric mean titer antibody calculated ass immunity whole group .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Patients &gt; 18 year old age Capable sign inform consent Suffering fibromyalgia ( ACR criterion ) Known allergy influenza vaccine Allergy egg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Fibromyalgia</keyword>
	<keyword>Influenza vaccination</keyword>
</DOC>